kaal:position:2026-07-31-1704

Single‐cell multi‐omics analysis identifies dynamic regulation of SREBF1 in Alzheimer’s disease should be assessed against Kaal's source-bound claim that Legacy ex-ante regulatory attempts fail because they assume a static technological landscape, while AI development is dynamic and requires rules that are adaptable and responsive. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

applies to legacy ex-ante and ex-post rulemaking
holds under exponential rates of technical change
External evidence level: abstract indexed.
Mapping review tier: mapping review before claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

Single‐cell multi‐omics analysis identifies dynamic regulation of SREBF1 in Alzheimer’s disease

Scholarly basis

kaal:claim:4796714-026
Wulf A. Kaal, AI Governance (2024). SSRN: https://ssrn.com/abstract=4796714
Source PDF sha256: 59fa63bae179e8f9b6b8efbdf90cee28400276512a1b04f9f579a48641305c93

Evidence and mapping

Evidence: abstract indexed
Review tier: mapping review before claim review
Mapping confidence: 0.28
Mapping ambiguous: true

Topics

dynamic-regulation

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0007 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: f1ce4bfb503b4e1285f723c7848cf41b36750dd385a13960317338bb683c9efb
curl -s https://wulfkaal.github.io/positions/2026-07-31-1704.md | sha256sum